Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up Following Earnings Beat tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wealthspire Advisors LLC bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,327 shares of the company’s stock, valued at approximately $87,000. Other institutional investors and hedge funds have […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Dean Y. Li sold 29,000 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $13.66, for a total transaction of $396,140.00. Following the completion of the transaction, the director now owns 421,000 […]